BRIM-P: A phase I, open-label, multicenter, dose-escalation...

  • Main
  • 2018 / 01
  • BRIM-P: A phase I, open-label, multicenter, dose-escalation...
Pediatric Blood & Cancer 2018 / 01

BRIM-P: A phase I, open-label, multicenter, dose-escalation study of vemurafenib in pediatric patients with surgically incurable, BRAF mutation-positive melanoma

Chisholm, Julia C., Suvada, Jozef, Dunkel, Ira J., Casanova, Michela, Zhang, Weijiang, Ritchie, Natasha, Choi, YounJeong, Park, Jane, Das Thakur, Meghna, Simko, Stephen, Wan Rachel Tam, Nga, Ferrari,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Pediatric Blood & Cancer
DOI:
10.1002/pbc.26947
Date:
January, 2018
File:
PDF, 848 KB
english, 2018
Conversion to is in progress
Conversion to is failed